Protea compacta
Connections displayed (default: 10).
Loading graph...
| Scientific Name | Protea compacta |
|---|---|
| Database Name | cmaup_plants |
| Synonyms | Protea Compacta |
| Ipni Id | 705701-1 |
| Plant Name | Protea Compacta |
| Genus Tax Id | 4331 |
| Disease Name | Hypotension, Dementia, Postoperative inflammation, Attention deficit hyperactivity disorder, Pulmonary hypertension, Mild neurocognitive disorder, Chronic pain, General pain disorder, Atopic eczema, Respiratory system disease, Oesophagitis, Mature T-cell lymphoma, Schizophrenia, Opioid use disorder, Acute/subacute hepatic failure, Spine/trunk injury, Type 2 diabetes mellitus, Multiple sclerosis, Vasomotor/allergic rhinitis, Herpes simplex infection, Acute diabete complication, Post-traumatic stress disorder, Pain, unspecified, Adaptive immunity immunodeficiency, Non-specific cutaneous vascular sympton, Retinopathy, Cushing syndrome, Otitis externa, Choreiform disorder, Muscular atrophy, Fungal infection, Sleep-wake disorder, Substance abuse, Adrenogenital disorder, Skin and skin-structure infection, Breast cancer, Narcolepsy, Solid tumour/cancer, Indeterminate colitis, Acute myeloid leukaemia, Chronic kidney disease, Rheumatoid arthritis, Glaucoma, Diabetes mellitus, type unspecified, Lupus erythematosus, Neuropathy, Depression, Allergic/hypersensitivity disorder, Alzheimer disease, Asthma, Chronic arterial occlusive disease, Irritable bowel syndrome, Dissociative neurological symptom disorder, Adrenomedullary hyperfunction, Prostate cancer, Mood disorder, Vitamin deficiency, Chronic obstructive pulmonary disease, Brain cancer, Muscular dystrophy, Obesity, Psoriasis, Somnolence, Asphyxia, Leukaemia, Sepsis, Ulcerative colitis, Precursor cell lymphoblastic leukaemia, NOS, Pneumonia, Myelodysplastic syndrome, Hepatic fibrosis/cirrhosis, Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified, Pancreatitis, Central nervous system disease, Cardiac arrest, Precursor B-lymphoblastic neoplasm, Nicotine use disorder, Congenital adrenal hyperplasia, Acute myelomonocytic leukaemia, Anaplastic large cell lymphoma, NOS, Adrenocortical insufficiency, Unspecified malignant neoplasms of unspecified sites, Influenza, Acute erythroid leukaemia, Septic shock, Chronic myelomonocytic leukaemia, Herpes simplex labialis, Adult T-cell lymphoma or leukaemia, human T-cell lymphotropic virus type 1-associated, Unspecific body region injury, Adenocarcinoma of prostate, Acquired adrenocortical insufficiency, Refractory anaemia, Chronic widespread pain, Melanoma, Acute megakaryoblastic leukaemia, Atrial fibrillation, Multiple myeloma, Primary haemophagocytic lymphohistiocytosis, Haemorrhoids, COVID-19, Adrenal cortical carcinoma, Viral pneumonia, Age-associated cognitive decline, Myeloproliferative neoplasm, Allergic conjunctivitis, Heart failure, Acute monocytic leukaemia, Bronchopulmonary dysplasia originating in the perinatal period, Anxiety or fear-related disorders, unspecified, Type1diabetesmellitus, Dermatitis or eczema, unspecified, Insulin-resistance syndromes, Refractory anaemia with excess of blasts, Myocardial infarction, Mast cell leukaemia, Ageing associated decline in intrinsic capacity, Acute leukaemias of ambiguous lineage, Alopecia areata, Personality disorder, severity unspecified, Burkitt-like lymphoma with 11q aberration, Diffuse large B-cell lymphoma, Oral submucous fibrosis, Alcohol dependence, Carcinosarcoma of uterus, Serous cystadenoma,borderline malignancy of ovary, Pheochromocytoma, Malignant neoplasms of biliary tract, distal bile duct, Hepatoblastoma, Adenocarcinoma of stomach, Diffuse large B-cell lymphomas, Myotonic dystrophy, West Nile virus infection, Adenocarcinoma of pancreas, Mesothelioma of pleura, Hepatocellular carcinoma of liver, Superficial ovarian endometriosis, Urothelial carcinoma of bladder, Cytomegaloviral disease, Malignant neoplasms of thyroid gland, unspecified, Adenocarcinoma of bronchus or lung, Malignant neoplasms of corpus uteri, unspecified, Chikungunya virus disease, Malignant neoplasms of thymus, Invasive carcinoma of breast, Germ cell tumour of testis, Malignant neoplasms of adrenal gland |
| Species Name | Protea compacta |
| Genus Name | Protea |
| Species Tax Id | 273580 |
| Disease Id | BA20-BA21, 6D80-6D8Z, 1A00-CA43, 6A05, BB01, 6D71, MG30, 8.00E+43, EA80, CB40-CB7Z, DA24, 2A90, 6A20, 6C43, DB91, ND51, 5A11, 8A40, CA08, 1F00, 5A2Y, 6B40, MG3Z, 4A01, ME64, 9B71, 5A70, AA00-AA13, 8A01, 8B61, 1F29-1F2F, 7A00-7B2Z, 6C40, 5A71, 1F28-1G0Z, 2C60-2C6Y, 7A20, 2A00-2F9Z, DD72, 2A60, GB61, FA20, 9C61, 5A14, 4A40, 8C0Z, 6A70-6A7Z, 4A80-4A8Z, 8A20, CA23, BD4Z, DD91, 6B60, 5A75, 2C82, 6A60-6E23, 5B55-5B5F, CA22, 2A00, 8C70, 5B80-5B81, EA90, MG42, MD11.1, 2A60-2B33, 1G40-1G41, DD71, XH5J37, CA40, 2A37, DB93, 1C62.Z, DC31-DC34, 8A04-8D87, MC82, 2A70, 6C4A, 5A71.01, XH78Y4, XH1LC0, 5A74, 2D4Z, 1E30-1E32, 2A60.35, XS26, 2A40, 1F00.01, 2A90.5, ND56, 2C82.0, 5A74.0, 2A30, MG30.01, 2C30, 2A60.36, BC81.3, 2A83, 4A01.23, DB60, 1D6Y, XH4KH2, CA40.1, MB21.0, 2A20, 9A60.02, BD10-BD1Z, XH9NE2, KB29.0, 6B0Z, 5A10, EA8Z, 5A44, 2A35, BA41-BA43, 2A21.00, MG2A, 2A61, ED70.2, 6D10.Z, XH8NN2, 2A81, DA02.2, 6C40.2, 2C76.43, 2C73.4, XH3854, 2C15, 2C12.01, 2B72.0, 8C71.0, 1D46, 2C10.0, 2C26.0, 2C12.02, GA10.B4, 2C94.2, 1D82, 2D10.Z, 2C25.0, 2C76.Z, 1D40, 2C27, 2C61, 2C80.2, 2D11 |
| Family Name | Proteaceae |
| Family Tax Id | 4328 |
- 1. (11s,12s,13s)-Epoxy-Hydroxyoctadeca-Cis-9-Cis-15-Dien-1-Oic Acid (PubChem CID: 10957878)
- 2. (1r,2r,5s,6r,9r,12r,13r,16s)-N,6,7,13-Tetramethyl-7-Azapentacyclo[10.8.0.02,9.05,9.013,18]icos-18-En-16-Amine (PubChem CID: 162908200)
- 3. (1r,2r,9r,12r,13r,16s,17r,18s,20s)-16-(Dimethylamino)-2,6,7,13,17-Pentamethyl-7-Azapentacyclo[10.8.0.02,9.05,9.013,18]icos-5-Ene-18,20-Diol (PubChem CID: 162968900)
- 4. (1r,2s,3s,5s,6s,9s,12s,13r)-3-Hydroxy-6,13-Dimethyl-7-Azapentacyclo[10.8.0.02,9.05,9.013,18]icosa-14,17-Dien-16-One (PubChem CID: 162950222)
- 5. (1r,2s,5s,6r,9r,12s,13r,16r)-N,n,6,13-Tetramethyl-7-Oxapentacyclo[10.8.0.02,9.05,9.013,18]icos-18-En-16-Amine (PubChem CID: 162908982)
- 6. (1r,2s,5s,6r,9r,12s,13r,16s)-N,n,6,13-Tetramethyl-7-Oxapentacyclo[10.8.0.02,9.05,9.013,18]icos-18-En-16-Amine (PubChem CID: 162908983)
- 7. (1r,2s,5s,6r,9r,12s,13s,16s,18s)-16-[(2r,4r,5r,6s)-5-Amino-4-Methoxy-6-Methyloxan-2-Yl]oxy-6,13-Dimethyl-7-Oxapentacyclo[10.8.0.02,9.05,9.013,18]icosane-2,6-Diol (PubChem CID: 162911602)
- 8. (1r,2s,5s,6s,9r,12r,13r)-N,6,13-Trimethyl-7-Azapentacyclo[10.8.0.02,9.05,9.013,18]icosa-16,18-Dien-16-Amine (PubChem CID: 162981974)
- 9. (1r,2s,5s,6s,9r,12r,13s,16s,18s)-16-[(2r,4r,5r,6r)-5-Amino-4-Methoxy-6-Methyloxan-2-Yl]oxy-6,13-Dimethyl-7-Oxapentacyclo[10.8.0.02,9.05,9.013,18]icosane-2,6-Diol (PubChem CID: 162911604)
- 10. (1r,2s,5s,6s,9r,12s,13r)-6,7,13-Trimethyl-7-Azapentacyclo[10.8.0.02,9.05,9.013,18]icosa-14,17-Dien-16-One (PubChem CID: 12310532)
- 11. (1r,2s,5s,6s,9r,12s,13r)-6-Ethyl-13-Methyl-7-Azapentacyclo[10.8.0.02,9.05,9.013,18]icosa-14,17-Dien-16-One (PubChem CID: 163014224)
- 12. (1r,2s,5s,6s,9r,12s,13r)-N,6,13-Trimethyl-7-Azapentacyclo[10.8.0.02,9.05,9.013,18]icosa-16,18-Dien-16-Amine (PubChem CID: 162981975)
- 13. (1r,2s,5s,6s,9r,12s,13r,16s)-6,13-Dimethyl-7-Azapentacyclo[10.8.0.02,9.05,9.013,18]icos-18-En-16-Amine (PubChem CID: 12303820)
- 14. (1r,2s,5s,6s,9r,12s,13r,16s)-6,7,13-Trimethyl-7-Azapentacyclo[10.8.0.02,9.05,9.013,18]icos-18-En-16-Amine (PubChem CID: 12303816)
- 15. (1r,2s,5s,6s,9r,12s,13r,16s)-7-Hydroxy-N,n,6,13-Tetramethyl-7-Azapentacyclo[10.8.0.02,9.05,9.013,18]icos-18-En-16-Amine (PubChem CID: 101529337)
- 16. (1r,2s,5s,6s,9r,12s,13r,16s)-N,5,6,13-Tetramethyl-7-Azapentacyclo[10.8.0.02,9.05,9.013,18]icos-18-En-16-Amine (PubChem CID: 162862285)
- 17. (1r,2s,5s,6s,9r,12s,13r,16s)-N,n,1,6,13-Pentamethyl-7-Azapentacyclo[10.8.0.02,9.05,9.013,18]icos-18-En-16-Amine (PubChem CID: 163028845)
- 18. (1r,2s,5s,6s,9r,12s,13r,16s)-N,n,1,6,7,13-Hexamethyl-7-Azapentacyclo[10.8.0.02,9.05,9.013,18]icos-18-En-16-Amine (PubChem CID: 163056295)
- 19. (1r,2s,5s,6s,9r,12s,13r,16s,20s)-16-(Dimethylamino)-6,7,13-Trimethyl-7-Azapentacyclo[10.8.0.02,9.05,9.013,18]icos-18-En-20-Ol (PubChem CID: 102093825)
- 20. (1r,2s,5s,6s,9r,12s,13s,16r,18r)-N,n,6,7,13-Pentamethyl-7-Azapentacyclo[10.8.0.02,9.05,9.013,18]icosan-16-Amine (PubChem CID: 162862856)
- 21. (1r,2s,5s,6s,9r,12s,13s,16s,18r)-N,n,6,7,13-Pentamethyl-7-Azapentacyclo[10.8.0.02,9.05,9.013,18]icosan-16-Amine (PubChem CID: 162862850)
- 22. (1r,3ar,5ar,5br,9s,11ar,11br,13ar,13br)-3a,5a,5b,8,8,11a-Hexamethyl-1-Prop-1-En-2-Yl-1,2,3,4,5,6,9,10,11,11b,12,13,13a,13b-Tetradecahydrocyclopenta[A]chrysen-9-Ol (PubChem CID: 162982170)
- 23. (1s)-1-[(3r,8s,9r,10r,13s,14r)-10,13-Dimethyl-3-(Methylamino)-2,3,4,7,8,9,11,12,14,15-Decahydro-1h-Cyclopenta[A]phenanthren-17-Yl]ethanol (PubChem CID: 162882885)
- 24. (1s)-1-[(3s,8r,9s,10r,13s,14s)-10,13-Dimethyl-3-(Methylamino)-2,3,4,7,8,9,11,12,14,15-Decahydro-1h-Cyclopenta[A]phenanthren-17-Yl]ethanol (PubChem CID: 162882884)
- 25. (1s,2r,5s,6r,9r,12s,13r,16r,18r)-N,n,6,7,13-Pentamethyl-7-Azapentacyclo[10.8.0.02,9.05,9.013,18]icosan-16-Amine (PubChem CID: 162862854)
- 26. (1s,2r,5s,6r,9r,12s,13s,16r)-6,7,13-Trimethyl-7-Azapentacyclo[10.8.0.02,9.05,9.013,18]icos-18-En-16-Amine (PubChem CID: 163013395)
- 27. (1s,2r,5s,6r,9r,12s,13s,16r)-N,n,6,13-Tetramethyl-7-Azapentacyclo[10.8.0.02,9.05,9.013,18]icos-18-En-16-Amine (PubChem CID: 162872759)
- 28. (1s,2r,5s,6r,9r,12s,13s,16r)-N,n,6,7,13-Pentamethyl-7-Azapentacyclo[10.8.0.02,9.05,9.013,18]icos-18-En-16-Amine (PubChem CID: 162847175)
- 29. (1s,2r,5s,6s,9r,12r,13s,16r,18s)-N,n,6,7,13-Pentamethyl-7-Azapentacyclo[10.8.0.02,9.05,9.013,18]icosan-16-Amine (PubChem CID: 162862855)
- 30. (1s,2r,5s,6s,9r,12r,13s,16s,18s)-N,6,7,13-Tetramethyl-7-Azapentacyclo[10.8.0.02,9.05,9.013,18]icosan-16-Amine (PubChem CID: 163044913)
- 31. (1s,2r,5s,6s,9r,12r,13s,16s,18s)-N,n,6,7,13-Pentamethyl-7-Azapentacyclo[10.8.0.02,9.05,9.013,18]icosan-16-Amine (PubChem CID: 162862852)
- 32. (1s,2r,9r,12r,13r,16r,18s)-N,6,13-Trimethyl-7-Azapentacyclo[10.8.0.02,9.05,9.013,18]icos-5-En-16-Amine (PubChem CID: 163076412)
- 33. (1s,2s,5s,6r,9r,11r,12r,13r)-6,11-Dihydroxy-6,13-Dimethyl-7-Oxapentacyclo[10.8.0.02,9.05,9.013,18]icosa-14,17-Dien-16-One (PubChem CID: 162888528)
- 34. (1s,2s,5s,6r,9r,11r,12s,13r)-6,11-Dihydroxy-6,13-Dimethyl-7-Oxapentacyclo[10.8.0.02,9.05,9.013,18]icosa-14,17-Dien-16-One (PubChem CID: 162888527)
- 35. (1s,2s,5s,6s,9r,11r,12s,13r)-11-Hydroxy-6,13-Dimethyl-7-Azapentacyclo[10.8.0.02,9.05,9.013,18]icosa-14,17-Dien-16-One (PubChem CID: 21573748)
- 36. (1s,2s,5s,6s,9r,11r,12s,13r)-11-Hydroxy-6,7,13-Trimethyl-7-Azapentacyclo[10.8.0.02,9.05,9.013,18]icosa-14,17-Dien-16-One (PubChem CID: 21573749)
- 37. (1s,2s,5s,6s,9r,12r,13r,16s,17r,18r,20s)-16-(Dimethylamino)-6,7,13,17-Tetramethyl-7-Azapentacyclo[10.8.0.02,9.05,9.013,18]icosane-18,20-Diol (PubChem CID: 162992393)
- 38. (1s,2s,5s,6s,9r,12r,13s,16s,18s)-16-[(2r,4s,5s,6s)-5-Amino-4-Methoxy-6-Methyloxan-2-Yl]oxy-6,13-Dimethyl-7-Oxapentacyclo[10.8.0.02,9.05,9.013,18]icosane-2,6-Diol (PubChem CID: 162911601)
- 39. (1s,2s,5s,6s,9r,12s,13r,16s,17r,18r,20r)-16-(Dimethylamino)-6,7,13,17-Tetramethyl-7-Azapentacyclo[10.8.0.02,9.05,9.013,18]icosane-18,20-Diol (PubChem CID: 101529338)
- 40. (1s,2s,5s,9r,11r,12s,13r)-11-Hydroxy-7,13-Dimethyl-7-Azapentacyclo[10.8.0.02,9.05,9.013,18]icosa-14,17-Diene-6,16-Dione (PubChem CID: 162926185)
- 41. (2r,3r,8r,9s,10r,13s,14s,16r,17z)-3-(Dimethylamino)-17-Ethylidene-10,13,14-Trimethyl-2,3,4,7,8,9,11,12,15,16-Decahydro-1h-Cyclopenta[A]phenanthrene-2,16-Diol (PubChem CID: 163049466)
- 42. (2r,3r,8s,9s,10r,13s,14s,17r)-17-Ethyl-2-Hydroxy-10,13-Dimethyl-3-(Methylamino)-1,2,3,4,7,8,9,11,12,14,15,17-Dodecahydrocyclopenta[A]phenanthren-16-One (PubChem CID: 129716280)
- 43. (2r,3r,8s,9s,10r,13s,14s,17r)-3-(Dimethylamino)-17-Ethyl-2-Hydroxy-10,13-Dimethyl-1,2,3,4,7,8,9,11,12,14,15,17-Dodecahydrocyclopenta[A]phenanthren-16-One (PubChem CID: 129716386)
- 44. (2r,3s,8s,9s,10r,13s,14s,17r)-17-Ethyl-2-Hydroxy-10,13-Dimethyl-3-(Methylamino)-1,2,3,4,7,8,9,11,12,14,15,17-Dodecahydrocyclopenta[A]phenanthren-16-One (PubChem CID: 162895144)
- 45. (2r,5s,6r,9r,12s,13s,16s,18r)-N,n,6,7,13-Pentamethyl-7-Azapentacyclo[10.8.0.02,9.05,9.013,18]icos-1(20)-En-16-Amine (PubChem CID: 163092171)
- 46. (2s,3r,4s,6r)-6-[[(1s,2r,5s,7s,10s,11r,14r,17s,18s)-10,17-Dimethyl-16,21-Dioxahexacyclo[15.3.1.01,14.02,11.05,10.014,18]henicosan-7-Yl]oxy]-4-Methoxy-2-Methyloxan-3-Amine (PubChem CID: 162853062)
- 47. (3r,3as,5as,10as,10bs)-5a,8-Dimethyl-10-Oxo-3-Propan-2-Yl-2,3,4,5,10a,10b-Hexahydro-1h-Cyclohepta[G]indene-3a-Carboxylic Acid (PubChem CID: 21668789)
- 48. (3r,8r,9s,10r,13s,14s,17s)-17-[(1r)-1-(Dimethylamino)ethyl]-N,n,10,13-Tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-Dodecahydro-1h-Cyclopenta[A]phenanthren-3-Amine (PubChem CID: 162936216)
- 49. (3r,8s,9r,10r,13s,14s,17s)-17-[(1s)-1-(Dimethylamino)ethyl]-N,n,10,13-Tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-Dodecahydro-1h-Cyclopenta[A]phenanthren-3-Amine (PubChem CID: 162936217)
- 50. (3r,8s,9s,10r,13s,14s,17r)-17-Ethyl-10,13-Dimethyl-3-(Methylamino)-1,2,3,4,7,8,9,11,12,14,15,17-Dodecahydrocyclopenta[A]phenanthren-16-One (PubChem CID: 102093813)
- 51. (3s,8r,9r,10r,13r,14r,17r)-10,13-Dimethyl-17-[(2r)-6-Methyl-5-Methylideneheptan-2-Yl]-2,3,4,7,8,9,11,12,14,15,16,17-Dodecahydro-1h-Cyclopenta[A]phenanthren-3-Ol (PubChem CID: 162940755)
- 52. (3s,8r,9r,10r,13r,14s,17s)-3-Amino-17-[(1s)-1-Aminoethyl]-13-(Hydroxymethyl)-10-Methyl-2,3,4,7,8,9,12,14,15,17-Decahydro-1h-Cyclopenta[A]phenanthrene-11,16-Dione (PubChem CID: 163031014)
- 53. (3s,8s,9s,10r,13s,14s,17s)-10,13-Dimethyl-17-[(1s)-1-(Methylamino)ethyl]-2,3,4,7,8,9,11,12,14,15,16,17-Dodecahydro-1h-Cyclopenta[A]phenanthren-3-Amine (PubChem CID: 102090481)
- 54. (3s,8s,9s,10r,13s,14s,17s)-17-[(1s)-1-(Dimethylamino)ethyl]-10,13-Dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-Dodecahydro-1h-Cyclopenta[A]phenanthren-3-Amine (PubChem CID: 162849568)
- 55. (Z,9r)-9-Hydroxyoctadec-12-Enoic Acid (PubChem CID: 5312848)
- 56. 1-[(2r,3r,8s,9s,10r,13s,14s,17s)-3-(Dimethylamino)-2-Hydroxy-10,13-Dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-Dodecahydro-1h-Cyclopenta[A]phenanthren-17-Yl]ethanone (PubChem CID: 129716339)
- 57. 11alpha-Hydroxyandrosta-1,4-Diene-3,17-Dione (PubChem CID: 111337)
- 58. 24-Ethylcholesta-5,23e-Dien-3beta-Ol (PubChem CID: 5283668)
- 59. 24-Methylenecholesterol (PubChem CID: 92113)
- 60. 3-[(3s,5s,8r,9s,10s,13r,14s,17s)-3-[(2r,4r,5r,6s)-5-Amino-4-Methoxy-6-Methyloxan-2-Yl]oxy-14-Hydroxy-10,13-Dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-Tetradecahydrocyclopenta[A]phenanthren-17-Yl]-2h-Furan-5-One (PubChem CID: 162941290)
- 61. 3-[(3s,5s,8r,9s,10s,13r,14s,17s)-3-[(2r,4s,5s,6r)-5-Amino-4-Methoxy-6-Methyloxan-2-Yl]oxy-14-Hydroxy-10,13-Dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-Tetradecahydrocyclopenta[A]phenanthren-17-Yl]-2h-Furan-5-One (PubChem CID: 162941287)
- 62. 3-Methoxy-4-Hydroxy-Cinnamic Acid (PubChem CID: 709)
- 63. 4-Hydroxyacetophenone (PubChem CID: 7469)
- 64. 5-Hydroxy-3,7,8,2'-Tetramethoxyflavone (PubChem CID: 14887327)
- 65. [(1r,2s,5s,6r,9s,10r,12r,13r,16s)-6,7,13-Trimethyl-16-(Methylamino)-7-Azapentacyclo[10.8.0.02,9.05,9.013,18]icos-18-En-10-Yl] 4-Methylpent-3-Enoate (PubChem CID: 162961612)
- 66. [(1s,2r,5r,6r,9s,12s,13s,16r)-16-(Dimethylamino)-6,13-Dimethyl-7-Azapentacyclo[10.8.0.02,9.05,9.013,18]icos-18-En-7-Yl]-[(1r,2s,5s,6s,9r,12s,13r,16s)-16-(Dimethylamino)-6,13-Dimethyl-7-Azapentacyclo[10.8.0.02,9.05,9.013,18]icos-18-En-7-Yl]methanone (PubChem CID: 163005790)
- 67. [(3r,8r,9s,10r,13r,14s,17s)-3-Amino-17-[(1s)-1-Aminoethyl]-10-Methyl-2,3,4,7,8,9,11,12,14,15,16,17-Dodecahydro-1h-Cyclopenta[A]phenanthren-13-Yl]methanol (PubChem CID: 15559631)
- 68. [(3r,8s,9s,10r,13r,14s,17r)-3-(Dimethylamino)-17-[(1r)-1-(Dimethylamino)ethyl]-10-Methyl-2,3,4,7,8,9,11,12,14,15,16,17-Dodecahydro-1h-Cyclopenta[A]phenanthren-13-Yl]methanol (PubChem CID: 162971838)
- 69. [(3r,8s,9s,10r,13r,14s,17r)-3-Amino-17-[(1s)-1-Aminoethyl]-10-Methyl-2,3,4,7,8,9,11,12,14,15,16,17-Dodecahydro-1h-Cyclopenta[A]phenanthren-13-Yl]methanol (PubChem CID: 162948660)
- 70. [(3s,5s,8r,9r,10s,13r,14s,17r)-10,13-Dimethyl-17-[(Z,2r)-5-Propan-2-Ylhept-5-En-2-Yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-Tetradecahydro-1h-Cyclopenta[A]phenanthren-3-Yl] Acetate (PubChem CID: 163062588)
- 71. [(3s,5s,8r,9s,10s,13s,14s,17r)-17-[(1s)-1-Acetamidoethyl]-10,13-Dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-Tetradecahydro-1h-Cyclopenta[A]phenanthren-3-Yl] Acetate (PubChem CID: 162922682)
- 72. [(3s,8r,9s,10r,13r,14s,17r)-3-(Dimethylamino)-17-[(1s)-1-(Dimethylamino)ethyl]-10-Methyl-2,3,4,7,8,9,11,12,14,15,16,17-Dodecahydro-1h-Cyclopenta[A]phenanthren-13-Yl]methanol (PubChem CID: 162971837)
- 73. [(3s,8r,9s,10r,13r,14s,17s)-3-(Dimethylamino)-17-[(1r)-1-(Dimethylamino)ethyl]-10-Methyl-2,3,4,7,8,9,11,12,14,15,16,17-Dodecahydro-1h-Cyclopenta[A]phenanthren-13-Yl]methanol (PubChem CID: 162971839)
- 74. [(3s,8r,9s,10r,13r,14s,17s)-3-(Dimethylamino)-17-[(1s)-1-(Dimethylamino)ethyl]-10-Methyl-2,3,4,7,8,9,11,12,14,15,16,17-Dodecahydro-1h-Cyclopenta[A]phenanthren-13-Yl]methanol (PubChem CID: 14543701)
- 75. [(3s,8s,9s,10r,13r,14r,17s)-3-(Dimethylamino)-17-[(1r)-1-(Dimethylamino)ethyl]-10-Methyl-2,3,4,7,8,9,11,12,14,15,16,17-Dodecahydro-1h-Cyclopenta[A]phenanthren-13-Yl]methanol (PubChem CID: 162971835)
- 76. Alpha-Pinene, (+)- (PubChem CID: 82227)
- 77. Cabraleone (PubChem CID: 21625900)
- 78. Chryseriol (PubChem CID: 5280666)
- 79. Con-5-Enin-12-Ol, 3-(Dimethylamino)-, 4-Methyl-3-Pentenoate (Ester), (3beta,12beta)- (PubChem CID: 11225162)
- 80. Conckurchine (PubChem CID: 76330309)
- 81. Conessidine (PubChem CID: 22214027)
- 82. Conessimine (PubChem CID: 12303831)
- 83. Conessine (PubChem CID: 441082)
- 84. Conimine (PubChem CID: 101686)
- 85. Holadysenterine (PubChem CID: 16742955)
- 86. Holanamine (PubChem CID: 76308534)
- 87. Holarrhenine (PubChem CID: 12310556)
- 88. Holarrhimine (PubChem CID: 15559632)
- 89. Hydrocortisone (PubChem CID: 5754)
- 90. Irehdiamine B (PubChem CID: 15560372)
- 91. Isoconessimine (PubChem CID: 11772257)
- 92. Kurchessine (PubChem CID: 442979)
- 93. Kurcholessine (PubChem CID: 20054951)
- 94. N,n-Dimethylconanin-5-En-3alpha-Amine (PubChem CID: 12303833)
- 95. N-[(1r,2s,5s,6s,9r,12s,13r,16s)-6,13-Dimethyl-7-Azapentacyclo[10.8.0.02,9.05,9.013,18]icosa-7,18-Dien-16-Yl]propan-2-Imine (PubChem CID: 162954229)
- 96. N-[(1s)-1-[(3r,5s,8r,9s,10s,13s,14s,17s)-3-Hydroxy-10,13-Dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-Tetradecahydro-1h-Cyclopenta[A]phenanthren-17-Yl]ethyl]acetamide (PubChem CID: 163017169)
- 97. N-[(1s)-1-[(3s,5s,8r,9r,10s,13s,14r,17s)-3-Hydroxy-10,13-Dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-Tetradecahydro-1h-Cyclopenta[A]phenanthren-17-Yl]ethyl]acetamide (PubChem CID: 163017170)
- 98. N-[(3s,8s,9s,10r,13s,14s,17s)-17-[(1s)-1-Formamidoethyl]-10,13-Dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-Dodecahydro-1h-Cyclopenta[A]phenanthren-3-Yl]acetamide (PubChem CID: 162858722)
- 99. Oryzalexin B (PubChem CID: 176496)
- 100. Paravallarine (PubChem CID: 442980)
- 101. Pregn-5-En-18-Ol, 20-Amino-3-(Methylamino)-, (3beta,20s)- (PubChem CID: 22214001)
- 102. Sorgoleone (PubChem CID: 6475682)
- 1. Addison Disease
- 2. Alopecia Areata
- 3. Alzheimer's Disease 1
- 4. Arthritis, Rheumatoid
- 5. Asthma
- 6. Cholera
- 7. Dementia
- 8. Dermatitis
- 9. Diabetes Mellitus
- 10. Diabetes Mellitus, Type 1
- 11. Esophagitis
- 12. Fibromyalgia
- 13. Glaucoma
- 14. Influenza, Human
- 15. Muscular Dystrophies
- 16. Myocardial Infarction
- 17. Obesity
- 18. Psoriasis
Not listed in any formulations.